top of page

Pipeline

biotech-innovation-drug-pipeline-poseidon.jpg

Pipeline

Phase 3

Phase 2

Target Validation

IND Studies

Phase 1

Phase 2

Phase 3

Target

Colon Cancer

Si44

Target: Xkr8(Oxp)

SMT1

Breast Cancer

Target: iRhom(Dox)

SMT1

SMT

NHL

Target: NTarget

Si44

NSCLC

SMT

Target: mutEGFR

SMT

flowsaber_httpss.mj.runAuw4cZcDglE_httpss.mj.runJnWTZ74hsyo_h_da6f91a5-14f3-449a-a441-b6b5

We built the Trident platform to enable targeting a wide range of cancers – our pipeline is led by POS001, aimed at NSCLC, and followed by other solid tumor indications as well as ALL.

Si44

Colon Cancer

Breast Cancer

44-FREE

NHL